Bombesin (BBN), a 14-amino-acid neuropeptide, has a very high affinity to gastrin-releasing peptide receptors (GRPrs) which are highly expressed in various cancers including prostate cancer, breast cancer, small cell lung cancer, and oral squamous cancer. The gene discussed is GRPR; the disease is prostate cancer.